FDA Approves Spring Boosters and Retires Monovalent Shots for COVID Vaccines.
The FDA has retired the original monovalent COVID-19 mRNA shots and streamlined immunizations for the unvaccinated, offering spring bivalent boosters to those aged 65 and older and people with certain immune compromising conditions. The only mRNA-based COVID-19 vaccines authorized and in use in the US will be the bivalent formulations from Moderna and Pfizer-BioNTech. Unvaccinated adults can now get just a single dose of a bivalent vaccine to complete the primary series, and all primary series doses for children and adults will also be the bivalent shot. Children and adults who have not yet received a dose of the bivalent vaccine as a booster are also eligible to get one.
- COVID vaccines: FDA retires monovalent shots, offers spring boosters to some Ars Technica
- F.D.A. Authorizes Another Covid Booster Shot for People Over 65 The New York Times
- FDA backs second omicron booster for high-risk groups The Washington Post
- New COVID vaccine guidance explained: Are you due for a shot? The Hill
- MEDIA CALL: Bivalent COVID-19 Vaccines – 4/18/2023 U.S. Food and Drug Administration
Reading Insights
0
9
2 min
vs 3 min read
79%
517 → 110 words
Want the full story? Read the original article
Read on Ars Technica